CLINICAL_TRIALS
trial_result
· 2016-03-17
Clinical Trial Update: Randomized Controlled Study of Donepezil in Fragile X Syndrome [Phase 2]
Summary
A Phase 2 randomized controlled trial evaluating donepezil in Fragile X Syndrome has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-03-17